ANI Pharmaceuticals ANIP FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ANI Pharmaceuticals's FX effect on cash?
- ANI Pharmaceuticals (ANIP) reported FX effect on cash of $156K in Q1 2026.
- How has ANI Pharmaceuticals's FX effect on cash changed year-over-year?
- ANI Pharmaceuticals's FX effect on cash increased by 152.5% year-over-year, from -$297K to $156K.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.